PeptiDream Inc. (TYO:4587)
Japan · Delayed Price · Currency is JPY 1,704.00
+24.00 (1.43%)
Dec 18, 2025, 11:30 AM JST
PeptiDream Employees
PeptiDream had 621 employees as of December 31, 2024. The number of employees increased by 18 or 2.99% compared to the previous year.
Employees
621
Change (1Y)
18
Growth (1Y)
2.99%
Revenue / Employee
23.72M JPY
Profits / Employee
-7.70M JPY
Market Cap
217.08B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 621 | 18 | 2.99% |
| Dec 31, 2023 | 603 | 34 | 5.98% |
| Dec 31, 2022 | 569 | 392 | 221.47% |
| Dec 31, 2021 | 177 | 27 | 18.00% |
| Dec 31, 2020 | 150 | 27 | 21.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| HOYA Corporation | 37,909 |
| Otsuka Holdings | 35,338 |
| Olympus | 29,297 |
| Daiichi Sankyo Company | 19,765 |
| M3, Inc. | 15,360 |
| Astellas Pharma | 13,643 |
| Kyowa Kirin | 5,669 |
PeptiDream News
- 14 hours ago - PeptiDream Announces Promising Pre-Clinical Results of Proprietary Oral IL-17A and IL-17F Dual Inhibitor with Biologic-Like Efficacy for the Treatment of Psoriasis - Business Wire
- 12 days ago - PeptiDream Inc. (PPTDF) Discusses Progress in Radiopharmaceuticals and Peptide Therapeutics Pipeline Transcript - Seeking Alpha
- 12 days ago - PeptiDream Inc. (PPTDF) Discusses Progress in Radiopharmaceuticals and Peptide Therapeutics Pipeline - Slideshow - Seeking Alpha
- 1 year ago - PeptiDream: Opulent Dream Now A Reality - Seeking Alpha